Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic human T-cell progenitors SMART 101

A preparation of allogeneic human T-cell progenitor cells, that can potentially be used for immune reconstitution purposes. Upon administration, the allogeneic human T-cell progenitors SMART 101 may accelerate immune reconstitution after T-cell-depleted allogeneic hematopoietic stem cell transplantation (HSCT) in patients with relapsed/refractory acute leukemia.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	allogeneic human T cell progenitor cells SMART 101 ProTcell
Code name:	SMART 101 SMART-101 SMART101

allogeneic human T-cell progenitors SMART 101

Search NCI's Drug Dictionary